Drug profile · INN
sapropterin
KUVAN
sapropterin (KUVAN) is a phenylalanine-4-hydroxylase activator. Associated with BioMarin Pharmaceutical Australia Pty Ltd.
EMA: approved TGA: approved Alimentary tract and metabolism (A16) A16AX07
Patents linked 0
Pipeline programs 22
News articles 0
Drug details — sapropterin
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 22
- Data quality
- 0.89
Quick answer
sapropterin (KUVAN) is a phenylalanine-4-hydroxylase activator. Associated with BioMarin Pharmaceutical Australia Pty Ltd.
Key facts
INN sapropterin
Brand KUVAN
Mechanism Phenylalanine-4-hydroxylase activator
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AX07
Originator BioMarin Pharmaceutical Australia Pty Ltd
Mechanism of action
Phenylalanine-4-hydroxylase activator
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sapropterin?
sapropterin (KUVAN) is a phenylalanine-4-hydroxylase activator. Associated with BioMarin Pharmaceutical Australia Pty Ltd.
What is the brand name for sapropterin?
KUVAN is a marketed brand name for sapropterin. Check FDA Drugs@FDA for the current US label holder and prescribing information.